子宫内膜癌患者治疗前全身免疫炎症指数的预后价值：一项荟萃分析
Prognostic value of pretreatment systemic immune-inflammation index in patients with endometrial cancer: a meta-analysis.
作者信息
Ji Pengtian, He Junjun
机构信息
Department of Oncological Radiotherapy, Huzhou Central Hospital, Affiliated Central Hospital of Huzhou University, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, Zhejiang, 313000, China.
Clinical Laboratory, Huzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Huzhou, Zhejiang, China.
出版信息
Biomark Med. 2024;18(7):345-356. doi: 10.2217/bmm-2023-0629. Epub 2024 Apr 16.
Abstract
The present work focused on evaluating the systemic immune-inflammation index (SII) for its role in predicting endometrial cancer (EC) patient prognosis by meta-analysis. SII's role in predicting the prognosis of EC patients was analyzed by calculating combined hazard ratios (HRs) and 95% CIs. As revealed by combined analysis, an increased SII predicted poor overall survival (HR = 2.01; 95% CI = 1.58-2.57; p < 0.001) as well as inferior progression-free survival (HR = 1.87; 95% CI = 1.36-2.58; p < 0.001) of EC. An increased SII score significantly predicted poor overall survival and progression-free survival in subjects with EC. The SII is suitable for predicting short- and long-term prognoses of patients with EC.
摘要
本研究通过荟萃分析，聚焦于评估全身免疫炎症指数（SII）在预测子宫内膜癌（EC）患者预后中的作用。通过计算合并风险比（HR）和95%置信区间（CI），分析SII在预测EC患者预后中的作用。综合分析显示，SII升高预示着EC患者的总生存期较差（HR = 2.01；95% CI = 1.58 - 2.57；p < 0.001）以及无进展生存期较差（HR = 1.87；95% CI = 1.36 - 2.58；p < 0.001）。SII评分升高显著预示着EC患者的总生存期和无进展生存期较差。SII适用于预测EC患者的短期和长期预后。
相似文献
1
Prognostic value of pretreatment systemic immune-inflammation index in patients with endometrial cancer: a meta-analysis.子宫内膜癌患者治疗前全身免疫炎症指数的预后价值：一项荟萃分析
Biomark Med. 2024;18(7):345-356. doi: 10.2217/bmm-2023-0629. Epub 2024 Apr 16.
2
Prognostic and clinicopathological significance of Systemic Immune-Inflammation Index in cancer patients receiving immune checkpoint inhibitors: a meta-analysis.免疫检查点抑制剂治疗癌症患者的全身免疫炎症指数的预后和临床病理意义：一项荟萃分析。
Ann Med. 2023 Dec;55(1):808-819. doi: 10.1080/07853890.2023.2181983.
3
Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma.术前全身免疫炎症指数作为尿路上皮癌患者的预后指标。
Front Immunol. 2023 Nov 20;14:1275033. doi: 10.3389/fimmu.2023.1275033. eCollection 2023.
4
Prognostic significance of pretreatment systemic immune-inflammation index in patients with prostate cancer: a meta-analysis.术前全身免疫炎症指数对前列腺癌患者预后的意义：一项荟萃分析。
World J Surg Oncol. 2023 Jan 5;21(1):2. doi: 10.1186/s12957-022-02878-7.
5
Prognostic role of C-reactive protein in patients with endometrial cancer: a meta-analysis.C-反应蛋白在子宫内膜癌患者中的预后作用：一项荟萃分析。
Biomark Med. 2024;18(6):279-289. doi: 10.2217/bmm-2023-0810. Epub 2024 Apr 19.
6
Prognostic value of systemic immune-inflammation index in patients with pancreatic cancer: a meta-analysis.系统免疫炎症指数对胰腺癌患者预后的价值：一项荟萃分析。
Clin Exp Med. 2022 Nov;22(4):637-646. doi: 10.1007/s10238-021-00785-x. Epub 2022 Jan 13.
7
Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis.术前全身免疫炎症指数对前列腺癌患者预后的价值：系统评价和荟萃分析。
J Transl Med. 2023 Feb 4;21(1):79. doi: 10.1186/s12967-023-03924-y.
8
Prognostic and clinicopathological value of systemic immune-inflammation index in patients with osteosarcoma: a meta-analysis.系统免疫炎症指数在骨肉瘤患者中的预后和临床病理价值：一项荟萃分析。
Front Immunol. 2024 Aug 15;15:1416068. doi: 10.3389/fimmu.2024.1416068. eCollection 2024.
9
Prognostic role of the pretreatment systemic immune-inflammation index in patients with glioma: A meta-analysis.预处理全身免疫炎症指数在胶质瘤患者中的预后作用：一项荟萃分析。
Front Neurol. 2023 Mar 8;14:1094364. doi: 10.3389/fneur.2023.1094364. eCollection 2023.
10
Prognostic significance of systemic immune-inflammation index in patients with ovarian cancer: a meta-analysis.全身免疫炎症指数在卵巢癌患者中的预后意义：一项荟萃分析。
Front Oncol. 2023 Jun 5;13:1193962. doi: 10.3389/fonc.2023.1193962. eCollection 2023.
引用本文的文献
1
Serum biomarkers and clinicopathologic postoperative prognostic factors for in endometrial cancer patients.子宫内膜癌患者的血清生物标志物及临床病理术后预后因素
Am J Transl Res. 2025 Jul 15;17(7):5063-5071. doi: 10.62347/VRHT7250. eCollection 2025.
2
Prognostic significance of systemic immune inflammation index for ovarian cancer: An updated systematic review and meta-analysis.全身免疫炎症指数对卵巢癌的预后意义：一项更新的系统评价和荟萃分析。
J Ovarian Res. 2025 Feb 27;18(1):41. doi: 10.1186/s13048-025-01626-1.
3
Effect of ultrasound-guided transverse abdominal plane block on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune inflammation index in patients undergoing radical resection of endometrial carcinoma.超声引导下腹横肌平面阻滞对子宫内膜癌根治性切除术患者中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及全身免疫炎症指数的影响。
PLoS One. 2024 Dec 5;19(12):e0315175. doi: 10.1371/journal.pone.0315175. eCollection 2024.
4
Preoperative prognostic nutritional index and systemic immune inflammation index for predicting the efficacy and survival time of patients with osteosarcoma undergoing neoadjuvant chemotherapy combined with surgery.术前预后营养指数和全身免疫炎症指数对预测骨肉瘤患者新辅助化疗联合手术的疗效及生存时间的价值
Am J Cancer Res. 2024 Oct 15;14(10):4946-4955. doi: 10.62347/MHXS8480. eCollection 2024.
5
Systemic immune-inflammatory index and platelet-to-lymphocyte ratio in intrahepatic cholestasis of pregnancy.系统性免疫炎症指数和血小板与淋巴细胞比值与妊娠肝内胆汁淤积症。
Saudi Med J. 2024 Nov;45(11):1217-1222. doi: 10.15537/smj.2024.45.11.20240760.
6
Inflammatory markers in systemic immune-inflammatory index and inflammatory response index to predict early pregnancy loss.全身性免疫炎症指数和炎症反应指数中的炎症标志物预测早孕丢失。
Saudi Med J. 2024 Aug;45(8):808-813. doi: 10.15537/smj.2024.45.8.20240404.
本文引用的文献
1
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
2
Development and validation of a nomogram based on multiple preoperative immunoinflammatory indexes for survival prediction in patients with stage IA-IB endometrial cancer.基于多种术前免疫炎症指标的列线图在IA-IB期子宫内膜癌患者生存预测中的开发与验证
Am J Transl Res. 2023 Oct 15;15(10):6286-6298. eCollection 2023.
3
Systemic Immune-Inflammation Index and Mortality in Testicular Cancer: A Systematic Review and Meta-Analysis.睾丸癌中的全身免疫炎症指数与死亡率：一项系统评价和荟萃分析
Diagnostics (Basel). 2023 Feb 22;13(5):843. doi: 10.3390/diagnostics13050843.
4
Novel long non-coding RNAs associated with inflammation and macrophage activation in human.新型长链非编码 RNA 与人的炎症和巨噬细胞活化有关。
Sci Rep. 2023 Mar 10;13(1):4036. doi: 10.1038/s41598-023-30568-1.
5
Systemic immune-inflammation index in predicting non-curative resection of endoscopic submucosal dissection in patients with early gastric cancer.系统免疫炎症指数预测早期胃癌内镜黏膜下剥离术非治愈性切除。
Eur J Gastroenterol Hepatol. 2023 Apr 1;35(4):376-383. doi: 10.1097/MEG.0000000000002528. Epub 2023 Feb 13.
6
Predictive Role of the Systemic Immune Inflammation Index for Intravesical BCG Response in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer.全身免疫炎症指数对中高危非肌肉浸润性膀胱癌膀胱内卡介苗反应的预测作用。
Urol Int. 2023;107(6):617-623. doi: 10.1159/000528740. Epub 2023 Feb 21.
7
Association between systemic immune-inflammation index (SII) and survival outcome in patients with primary glioblastoma.系统免疫炎症指数（SII）与原发性脑胶质瘤患者生存结局的关系。
Medicine (Baltimore). 2023 Feb 17;102(7):e33050. doi: 10.1097/MD.0000000000033050.
8
The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy.术前全身免疫炎症指数与新辅助治疗后接受根治性切除的食管鳞癌患者的不良预后相关。
Surg Today. 2023 Aug;53(8):964-972. doi: 10.1007/s00595-023-02658-0. Epub 2023 Feb 16.
9
Prognostic value of systemic immune-inflammation index in non-metastatic clear cell renal cell carcinoma with tumor thrombus.全身免疫炎症指数在伴有肿瘤血栓的非转移性透明细胞肾细胞癌中的预后价值
Front Oncol. 2023 Jan 26;13:1117595. doi: 10.3389/fonc.2023.1117595. eCollection 2023.
10
Prognostic value of the pretreatment systemic immune-inflammation index in patients with prostate cancer: a systematic review and meta-analysis.术前全身免疫炎症指数对前列腺癌患者预后的价值：系统评价和荟萃分析。
J Transl Med. 2023 Feb 4;21(1):79. doi: 10.1186/s12967-023-03924-y.
Zotero 插件